Source: Clinical therapeutics. Unidade: FM
Subjects: INSULINA, GLICEMIA, HIPOGLICEMIA, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, INSUFICIÊNCIA RENAL CRÔNICA
ABNT
BETONICO, Carolina C et al. Insulin glargine U100 improved glycemic control and reduced nocturnal hypoglycemia in patients with type 2 diabetes mellitus and chronickKidney disease stages 3 and 4. Clinical therapeutics, v. 41, n. 10, p. 2008-2020, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2019.07.011. Acesso em: 18 nov. 2024.APA
Betonico, C. C., Titan, S. M. O., Lira, A., Pelaes, T. S., Giannella, M. L. C. C., Nery, M., & Queiroz, M. (2019). Insulin glargine U100 improved glycemic control and reduced nocturnal hypoglycemia in patients with type 2 diabetes mellitus and chronickKidney disease stages 3 and 4. Clinical therapeutics, 41( 10), 2008-2020. doi:10.1016/j.clinthera.2019.07.011NLM
Betonico CC, Titan SMO, Lira A, Pelaes TS, Giannella MLCC, Nery M, Queiroz M. Insulin glargine U100 improved glycemic control and reduced nocturnal hypoglycemia in patients with type 2 diabetes mellitus and chronickKidney disease stages 3 and 4 [Internet]. Clinical therapeutics. 2019 ; 41( 10): 2008-2020.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.clinthera.2019.07.011Vancouver
Betonico CC, Titan SMO, Lira A, Pelaes TS, Giannella MLCC, Nery M, Queiroz M. Insulin glargine U100 improved glycemic control and reduced nocturnal hypoglycemia in patients with type 2 diabetes mellitus and chronickKidney disease stages 3 and 4 [Internet]. Clinical therapeutics. 2019 ; 41( 10): 2008-2020.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.clinthera.2019.07.011